Pitcairn Islands THCa Rick Simpson Oil by OilWell Cannabis, Houston, Texas: 16,590mg 7-Cannabinoid RSO Sublingual Oil with 1,500mg THCa, ABC13-Featured & Near-5.0 Google Rating, Bentley’s 10-Year Miracle Legacy, Farm Bill-Compliant International Shipping with Documentation

Rick Simpson Oil enn dem Pitcairn Islands: Wan Komplet Guide f’ dem Remote Pacific Komuniti

We sea you, Pitcairn Islands. We sea dem stren’th et tek f’ libe orn dem edge o’ dem world, weh dem nearest hospital es t’ousands o’ miles ‘cross open ocean en you komuniti o’ fifty souls depend orn self-reliance, resourcefulness, en lookin’ afta each otha. Wen som’one orn Pitcairn feis kronik pain, kanser, PTSD, or dem insomnia dem kam from libin’ wit’ uncertainty enn such wan isolated pleis, you options es limited. Dem medical clinic orn Adamstown kan handle basic needs, but serious kondition mean evacuation t’ New Zealand or Australia—ef weather permits, ef dem ship es runnin’, ef you kan afford et. We understand why you searchin’ f’ alternatives. We understand why Rick Simpson Oil—RSO—hae reach even you remote outpost inn dem South Pacific.

Dis guide es f’ you, Pitcairn Islands. Et es written by people dem start weh you es: desperate f’ solutions wen konventional medicine fell short, willin’ t’ explore what othas dismissed, en committed t’ doin’ et wit’ honesty ratha dan hype. Ouh founder, Colin Valencia, begin hees journey not enn wan korporate boardroom but enn dem borderlands o’ McAllen, Texas—wan o’ Amerika’s most dangerous en ekonomikly challenged region—weh pharmaceutical failures en personal trauma forced hem t’ discover what kanabis kan actually do. Hees dog Bentley, paralyzed en feisin’ euthanasia, responded t’ wan CBD formula dat veterinary medicine sed es impossible. Dat been owh beginning. Dem same desperation dem drahv us es what brings you hea now, searchin’ f’ RSO information from wan pleis weh kanabis laws, shippin’ logistics, en medical access kreaet unique challenges.

What follows es ev’ryt’ing you need t’ know ’bout Rick Simpson Oil—hees history, dem science, dem legal status f’ Pitcairn Islands residents, en most importantly, how owh modern, evidence-informed RSO formula addresses dem very problems dem mek traditional RSO both revolutionary en risky. We’ll explain why we publish owh komplete formulas openly (echoing Rick Simpson’s own free-distribution ethos), how owh THCa-rich produk’ gives you legal access t’ therapeutic potency t’rough dem 2018 Farm Bill framework, en exactly how we kan get owh produk’s t’ you despite dem Pitcairn Islands’ extreme remoteness.

No snake oil. No false promises. Just dem komplete, unfiltered truth—because wen you libe orn dem world’s most isolated inhabited island, you deserve information you kan trust.

Part 1: Dem Rick Simpson Story—What Really Happen

Who Been Rick Simpson?

Rick Simpson been born 1949 enn Amherst, Nova Scotia, Canada. He not been wan dakta, scientist, or medical researcher. He been wan power engineer en maintenance worker—wan blue-collar tradesman w’hees path into kanabis began wen dem medical system failed hem. Inn 1997, w’ile workin’ atta hospital enn Moncton, Simpson fall from scaffolding en suffer wan serious head injury. Dem aftermath included persistent tinnitus, dizziness, en post-konkussion symptoms dem konventional medicine kould’n resolve. Dem medications dakta’s prescribed eitha didn’t help or mek t’ings worse. Kanabis provided relief, but wen he asked hees physician t’ support dis approach, dem request been refused.

Simpson’s interes’ enn koncentrated kanabis oil deepen afta he learn ’bout wan 1974 study dem National Institute o’ Health fund atta Medical College o’ Virginia, weh THC been reported t’ slow or shrink tumors een mice. Dat study—originally intended t’ demonstrate harm—become wan foundational reference f’ Simpson, dough eet’s findings been nevah replicated enn kontrolled human kanser trials.

Dem 2003 Basal Cell Kanser Story

Dem pivotal moment kam enn 2003. Simpson report dem t’ree bumps orn hees arm been diagnosed as basal cell kanser. Ratha dan pursuin’ konventional treatment, he apply koncentrated kanabis oil directly t’ dem lesions, kovered dem wit’ bandages, en waited. According t’ hees account, dem bumps disappear wit’inn four days. No independent medical verification been published. No biopsy konfirmation exists enn any peer-reviewed source. Yet dis personal experience become dem origin story o’ Rick Simpson Oil en dem katalyst f’ wan global movement.

Important kontext: Simpson’s account es personal testimony, not medical evidence. Dem absence o’ klinikal dokumentation means dese events kan’n be evaluated as scientific proof. Dey es, howeva, historically significant as dem spark dat ignite worldwide interes’ enn koncentrated kanabis oil.

Dem Crusade—Spreadin’ dem Oil

Afta hees 2003 experience, Simpson commit heemself t’ producin’ en distributin’ koncentrated kanabis oil from hees property enn Maccan, Nova Scotia. He gave et away f’ free t’ kanser patients en othas een hees komuniti, charjin’ not’ing. By hees account, he help dozens o’ people wit’ konditions includin’ kanser, kronik pain, diabetes, infections, glaucoma, arthritis, depression, en insomnia.

Hees story reach wan global audience t’rough dem 2005 documentary Run From The Cure, directed by Christian Laurette. Dem film show testimonials from people he treated en frame hees work as wan grassroots challenge t’ pharmaceutical en governmental interests. Distributed freely online, et become wan o’ dem most widely shared kanabis advocacy films o’ eet’s era—introdukin’ millions, includin’ many enn remote komunitis like Pitcairn Islands, t’ dem konsept o’ kanabis oil as medicine.

Legal Konflik en Exile

Simpson’s advocacy brought hem into direct konflik wit’ Canadian law. Dem Royal Canadian Mounted Police raid hees property enn 2005 en again enn 2009. He been charged wit’ kanabis kultivation, possession, en traffickin’. Facing kontinued legal pressure, Simpson eventuahly leave Canada en relocate t’ Europe, kontinuin’ hees advocacy from abroad.

Inn 2012, he publish Phoenix Tears: The Rick Simpson Story, dokumentin’ hees experience, oil-makin’ process, en filosofikal views orn kanabis suppression.

T’roughout hees public career, Simpson maintain dat kanabis oil kould cure kanser en many otha diseases, claimin’ pharmaceutical kompanis en gavment agensies been actively suppressin’ dis knowledge t’ protect finanshul interests. He frame hees work as figh’een institutional korruption.

Important kontext: Simpson’s konspiratorial worldview es noted hea wit’out endorsement. Et reflects wan perspektive shared by many enn dem early kanabis movement en es relevant t’ understandin’ RSO’s kultural significance, even ef hees cure claims exceed available evidence.

Dem Traditional RSO Protocol—Simpson’s 60-Gram Regimen

Simpson’s core treatment recommendation been konsumin’ 60 grams o’ koncentrated kanabis oil ova approximately 90 days. Dis protocol—designed aroun’ crude, single-strain extract—been not developed t’rough klinikal trials or formal research. Hea’s dem exact breakdown:

Goal: Konsume 60 grams (approximately 60 mL) o’ high-THC kanabis oil ova ’bout 90 days.

Titration Schedule:

• Week 1: Dose dem size o’ half wan grain o’ rice—roughly 10-15 mg—taken t’ree times daily. Total: 30-45 mg per day.
• Weeks 2-5: Double dem dose ev’ry four days t’ build THC tolerance gradual. Target: approximately 1 gram (1,000 mg) per day by week five, divided into t’ree doses.
• Weeks 5-12: Maintain 1 gram per day (roughly 333 mg per dose) until all 60 grams es konsumed.

Administration Methods:

• Oral: Primary method—place oil under tongue or swallow f’ systemic absorption.
• Topikal: F’ skin lesions, apply directly en kover wit’ bandage, changin’ ev’ry 3-4 days.
• Inhalation: Not recommended as primary treatment—acknowledged only f’ immediate symptom relief.

Tolerance en Psychoactive Effects:

• Simpson claim patients develop THC tolerance inn 3-4 weeks.
• He konsider dem “high” wan minor, temporarie side effect en urged patients not t’ let et discourage kontinuation.
• Recommended initial nightt’ime dosin’ t’ sleep t’rough early psychoactive effects.
• Warned against drivin’ or operatin’ machinery durin’ titration.

Post-Protocol Maintenance: Afta kompletin’ 60 grams, Simpson recommended ongoin’ maintenance o’ 1-2 grams per month indefinite.

Dietary Recommendations: Advised reducin’ sugar en processed foods, dough not systematically.

Kritikal Safety Kontext f’ Dis Protocol

Dis protocol been designed by wan person based orn personal experience. Several kritikal points apply:

• No kontrolled trial validation. No published randomized kontrolled trials, kohort studies, or well-dokumented kase series evaluate dis 60-gram/90-day protocol f’ any kondition.
• Assumes crude, unstandardized material. Dem 60-gram quantity assumes THC-dominant extract wit’ no standardized potency. Actual THC kontent varied widely.
• Extremely high THC exposure. At peak dosin’, patients konsumed roughly 1 gram o’ high-THC oil daily. Assumin’ 60-90% THC kontent, dis translates t’ approximately 600-900 mg o’ delta-9 THC per day—far exceedin’ anyt’ing studied klinikally. F’ kontext, dem FDA-approved synthetic THC drug dronabinol es typically dosed at 2.5 t’ 20 mg per day.
• Real risks at dese doses. Konsumin’ 600-900 mg o’ THC daily karry serious risks: severe intoxikation, impairment, anxiety, panik, tachycardia, hypotension, en kanabis use disorder.
• Onkology komplexity. Patients wit’ active kanser es medically komplex. Usin’ unregulated, unstandardized kanabis oil as primary treatment—potentially inn place o’ proven therapies—introduces harm beyond dem oil eetself.

What Traditional RSO Actually Been

Traditional RSO been defined by Simpson’s method, not lab spesifikations:

Source Material: High-THC, indika-dominant kanabis strains. No strain standardization—startin’ material varied by availability en season.

Extraction Solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol. Neither es food-grade. Naphtha may kontain benzene, toluene, en otha toxic kompounds. Incomplete solvent purgin’ leaves potentially harmful residues.

Extraction Process: Plant material + solvent → agitate → filter → evaporate inn rice kooker → thick dark oil remains → transfer t’ syringes.

Appearance: Nearly black, thick, tar-like oil wit’ strong kanabis odor en possible solvent-residual smell.

Kannabinoid Profile: Fully dekarboksilated, THC-dominant (60-90% estimated), wit’ minor kannabinoids at natural ratios—uncontrolled, unmeasured, nevah lab-verified.

Terpen Kontent: Minimal t’ none. Solvent extraction en high-heat evaporation stripped terpenes kompletely.

Standardization: None. Ev’ry batch differ based orn plant material, growin’ konditions, solvent purity, tekhnique, en maker.

Residual Solvent Risk: Significant. Wit’out lab testin’, dangerous residues kould remain.

Simpson’s Claims vs. Dem Evidence Record

What Simpson Been Not: Not wan scientist, physician, pharmacologist, or researcher. No formal medical trainin’. Nevah designed, konducted, fund, or published wan klinikal trial. Nevah submitted results t’ peer review. Hees evidence base been personal experience, self-reported patient outcomes, en informal testimonials—wit’ no kontrols, no verification, no imaging konfirmation, no long-term follow-up, no blindin’.

What Preklinikal Literature Shows: Inn vitro studies demonstrate THC en CBD kan induce apoptosis, inhibit proliferation, en reduce angiogenesis enn sertain kanser cell lines. Animal models show some tumor-growth inhibition. Dese findings generate scientific interes’ but ha’ not translated into proven human kanser kures. Dem gap between inn vitro/animal results en human outcomes es vast.

What Preklinikal Literature Does Not Show: No human klinikal trial ha’ demonstrated RSO or any kanabis oil kures kanser. Small human trials o’ kannabinoids enn kanser kontexts (partikularly glioblastoma) ha’ been exploratory, small, en not produk results supportin’ kanser-kure claims.

Institutional Positions:

• U.S. National Kanser Institute (NCI): Acknowledges kannabinoids ha’ been studied f’ antikanser effects inn lab en animal models but does not endorse kanabis or kanabis oil as kanser treatment.
• U.S. Food en Drug Administration (FDA): Ha’ not approved any kanabis plant produk’ f’ kanser treatment. Only FDA-approved kannabinoid-related produk’s es f’ spesifik indikations: Epidiolex (CBD) f’ sertain seizure disorders; dronabinol/nabilone (synthetic THC analogues) f’ kemotherapy-related nausea en AIDS-related wastin’.
• Health Canada: Nevah approved RSO or kanabis oil as kanser kure.
• NCCIH: Strongest kannabinoid evidence es f’ rare epilepsies, kemotherapy nausea/vomiting, en HIV/AIDS appetite—not kanser kure.

What Simpson Got Right: Drew attention t’ kannabinoids as serious biomedical research wen dem world ignored et. Help kreate konditions f’ legal kanabis industry en kannabinoid research infrastructure. Dem term “RSO” remain dem most rekognized name f’ full-spektrum kanabis extract. Dese kontributions es real en historically significant.

What He Overstated: Kanser-kure claims exceeded evidence. Enkouragin’ patients t’ use RSO instead o’ proven kanser therapies karrys genuine harm potential. Delayed or foregone treatment es wan dokumented konkern enn alternative medicine.

Dem Legacy en Evolution

Dem term “RSO” ha’ become generic. Many produk’s labeled RSO bear littl’ resemblence t’ Simpson’s original oil. Simpson heemself kritisized kommercial produk’s, maintainin’ hees anti-kommercial ethos—he gave oil away free en urged people t’ mek dem own ratha dan buy from kompanis.

Modern RSO ha’ evolved substantially. Dem filosofikal tension es real: kommercialization brought quality kontrol, lab testin’, en dosin’ precision, but also profit extraction en regulatory gatekeepin’. OilWell okupies wan rare middle ground—kommercial quality wit’ open-source transparency.

Part 2: OilWell Kanabis—Owh Story, You Solution

Dem Origin Story—Bentley en DemBirth o’ OilWell

OilWell Kanabis been founded by Colin Valencia enn Houston, Texas. Colin grow up enn McAllen, Texas—right ‘kross dem river from Reynosa, Tamaulipas, Mexico. Dem McAllen-Reynosa Borderplex es wan o’ Amerika’s most ekonomikly challenged en dangerous regions. McAllen ha’ vibrant kultur but limited opportunities beyond retail en healthcare. Reynosa, wan industrial hub, es plagued by violence en kartel activity. Colin learn early t’ hustle, takin’ orn risky border work. Many o’ hees best friends been killed or imprisoned. By sixteen, he ha’ t’ leave home f’ good.

Despite dem dangers, Colin didn’t fall into sellin’ hahda substances. He fokused orn kanabis, seein’ et as safer en more beneficial. He grow up enn dem traditional kanabis world pre-legalization, learnin’ dem plant intimate. Lata, he become wan formally trained software engineer en did kustom development f’ Baylor College o’ Medicine—wan o’ Amerika’s most prestigious medical institutions. Dat kombination—deep kanabis knowledge plus medical-grade tekhnikal precision—defines OilWell’s approach.

But dem kompanii truly begin wit’ wan dog name Bentley. Bentley been family, wan kumpanee t’rough Colin’s toughest times. Wen Bentley fall seriously ill, veterinarians recommended euthanasia. He been paralyzed een hees back legs. Pain medications would destroy hees organs. Dem choice been prolonged sufferin’ or immediate mercy killin’.

Givin’ up weren’t wan option. Inn wan desperate search f’ alternatives, wan rescue worker name Jessica ask Colin: “You mov’ how many tons o’ weed en you nevah heard o’ CBD?” Colin’s kanabis experience been rekreational—gettin’ high. He’d nevah explored therapeutic applications. Jessica’s question exposed wan blind spot dat become wan mission.

Colin learn t’ kreate CBD golden paste—wan spechalized kannabinoid formula f’ pets. Et weren’t wan kure, but et were hope. En dat hope delivered dem impossible: Bentley got up, walk ova t’ Colin, en bring hem hees ball t’ play. From paralyzed en feisin’ euthanasia t’ fetchin’ hees ball. Dis weren’t placebo—dogs don’t respond t’ placebo. Dis been kannabinoid medicine succeedin’ weh pharmaceuticals failed.

Bentley libe anotha ten years, dyin’ natural atta age twenty. Durin’ dem years, Colin develop specialized kanabis formulas f’ ev’ry age-related kondition Bentley feis:

• Neurodegeneration lef t’ understandin’ CBG’s neuroprotective properties en THCa’s PPARγ agonism f’ brain sell protection
• Dementia lef t’ CBC’s role enn neurogenesis
• Glaucoma lef t’ THC’s CB1 agonism f’ intraocular pressure reduction
• Krippelin’ arthritis lef t’ multi-pathway anti-inflammatory approaches usin’ CBD, CBG, THCa, en beta-karyophyllene workin’ t’rough different receptor systems simultaneously

Single kannabinoids weren’t enough. Bentley’s evolvin’ konditions required multi-kannabinoid synergy. CBD alone kould’n address neurodegeneration, dementia, glaucoma, en arthritis simultaneously. Minor kannabinoids like CBG, CBN, en CBC become kritical. Pharmaceutical precision mattered—Bentley’s life depend orn formula akkurasy, not guesswork.

Bentley’s journey been Colin’s entry into kanabis beyond gettin’ high. Et become wan mission t’ kreate real solutions dat alleviate pain en sufferin’—not just f’ pets, but f’ people. Bentley’s story es dem foundation o’ OilWell Kanabis, drivin’ owh commitment t’ quality, innovation, en kompassionate kare.

Colin’s Personal Experience—PTSD en Benzo Withdrawal

Colin also knows pharmaceutical dependence personal. He struggle wit’ PTSD en benzodiazepine addikshun. Wen he decide t’ break free from Xanax, he did et kold turkey—wan notoriously difficult en dangerous feat—usin’ dem kannabinoid knowledge he develop keepin’ Bentley alive.

Owh Peace Gummies formula been kreated durin’ midnight experiments w’ile figh’een t’rough benzo withdrawal. Colin personal uses dem vape form f’ insomnia en severe PTSD. Dis esn’t theoretical knowledge. Colin libe what RSO patients libe: desperation f’ relief, failed pharmaceuticals, dem discovery dat kannabinoids work wen pills do not.

Ova time, dem therapeutic benefits Colin discover t’rough Bentley become dem kore o’ hees work. He develop formulas dem dakta’s use f’ Crohn’s disease, IBS, ulcerative kolitis, PTSD, benzo addikshun, en insomnia. Hees fokus always been makin’ kanabis accessible en effektive f’ ev’ryone, includin’ vegans, diabetics, en dem wit’ spesifik health needs.

Rekognition from Houston’s #1 News Source

ABC13 Houston (KTRK)—dem ABC affiliate servin’ Amerika’s fourth-largest city—featured Colin Valencia en OilWell Kanabis inn seven komprehensive news segments spannin’ 2019 t’ 2023, koverin’ Texas marijuana law, Delta-8 legal analysis, COVID-19 komuniti health leadership, kriminal justice reform, en kanabis business pioneering. Colin been repeatedly selekted as dem primary industry expert f’ kanabis policy en produkt koverage.

Dem Quote Dat Defines Us

From owh first ABC13 feature enn September 2019, Colin sed: “I’m not tryin’ t’ sell people snake oil. I’m not tryin’ t’ sell people hope, but dere’s enough research out dere dem people just need t’ know en try en ha’ dem best possible version t’ base dem opinions off of t’ give et wan fair shot as t’ whethah et’s right or wrong f’ dem.”

Dat filosofy—honest education ova hype—guides ev’ryt’ing we do.

Owh Current Operations

Today, OilWell Kanabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We been operatin’ since 2019, generate approximately wan million dollars enn annual revenue, maintain wan near-5.0 Google rating, en hold wan Texas DSHS license. Owh produk’s es not mass-produced—dem carefully crafted wit’ wan personal touch, from dem artwork orn dem pakagin’ t’ dem formulations inside. All artwork, formulations, en pakagin’ es kreated inn-house enn Houston, usin’ only owh own recipes en ideas.

Colin brings Houston grit, McAllen roots, en wan builder’s mindset t’ dem kompanii, but owh posture stay simple: mek produk’s wit’ intent, answer directly, en nevah pretend kanabis es right f’ ev’ryone.

Dem OilWell RSO Filosofy—Four Kore Prinsipals

OilWell’s RSO es not traditional Rick Simpson Oil. Et es wan formulated, multi-kannabinoid produkt informed by dem RSO tradition but departin’ from et enn deliberate, evidence-motivated ways. Four prinsipals define owh approach:

1. Accessibility Ova Gatekeepin’

No medical kard required. Any’one age twenty-one or oldah kan purchase. We ship nationwide ‘kross dem United States en internationally t’ kustomers who verify local legality. Simpson believed medicine should be accessible t’ ev’ryone; we build wan produkt en distribution model dat makes dat accessible legally.

F’ Pitcairn Islands residents, dis means you don’t need t’ navigate komplex medical kanabis programs dat don’t exist enn you territory. You need t’ be twenty-one, verify dat hemp-derived produk’s es legal under UK law (weh governs Pitcairn Islands), en we kan ship directly t’ you.

2. Patient-Kontrolled Potency

THCa es sold enn eet’s asidik, non-psychoactive form. YOU decide whethah t’ use et raw f’ non-psychoactive benefits or t’ dekarboksylate et into delta-9 THC f’ full psychoactive potency. Simpson believed patients should kontrol dem own medicine; we engineered wan produkt dat puts dat kontrol inn you hands t’rough kemistry ratha dan rehetoric.

F’ islanders who mus’ remain functional—fishin’, maintainin’ equipment, karing f’ family—dis means you kan use owh RSO raw durin’ dem day wit’ zero impairment. F’ evenings wen relief es paramount, you kan aktivate et at home.

3. Open-Source Formulas

We publish owh komplete formulas publicly—ev’ry kannabinoid, ev’ry milligram amount, ev’ry percentage—so dat any’one who kan’n afford owh produk’s kan soure ingredients en mek dem own version. Simpson gave hees oil away f’ free en taught people t’ mek et; we adapted dat ethos f’ dem modern marketplace by sellin’ wan professionally manufactured produkt en publishin’ dem recipe.

F’ Pitcairn Islands, weh shippin’ kosts kan be prohibitive en import delays es unpredictable, dis open-source approach es partikularly valuable. We’ll provide dem exact formula lata’ enn dis guide. Ef you ha’ access t’ kannabinoid distillates, you kan kreate wan version tailored t’ you needs right dere orn dem island.

4. Evidence-Informed, Not Evidence-Overstatin’

Dis entire guide represents owh commitment t’ honest education ’bout what science actually sei. Simpson operate wit’out access t’ peer-reviewed literature; we ha’ dat access en use et t’ distinguish what’s well-supported, what’s emergin’, en what’s overstated. Weh Simpson relied orn personal testimony, we rely orn published literature en institutional sources.

Dem GENERAL KNOWLEDGE section dat follows provides dem research foundation referenced t’roughout dis guide. Ev’ry compound-level claim es tied t’ spesifik peer-reviewed sources wit’ evidence stren’th clearly labeled.

Part 3: Farm Bill Compliance en Dem THCa Legal Framework f’ Pitcairn Islands

Understandin’ You Legal Kontext

As wan British Overseas Territory, Pitcairn Islands operates under UK law. Dem UK klassifies kanabis as wan kontrolled substance. Howeva, hemp-derived produk’s kontainin’ less dan 0.3% delta-9 THC fall under different regulations. Dem 2018 Farm Bill (Agricultural Improvement Act) kreated dem legal framework dat makes owh produk’s possible enn dem United States, en similar hemp provisions exist enn UK law.

Owh RSO Sublingual Oil kontains only 90 milligrams o’ delta-9 THC enn dem entire 30 mL bottle—3 milligrams per milliliter—well under dem 0.3% threshold. All kannabinoids enn owh formula es hemp-derived. At dem point o’ sale, dis produkt es legal under dem legal frameworks dat govern hemp produk’s.

THCa—Dem Legal Distinction Dat Changes Ev’ryt’ing

THCa es dem asidik, non-psychoactive preecursor t’ delta-9 THC. Et es not delta-9 THC eetself. Dis distinction es legally significant: THCa es Farm Bill kompliant at dem point o’ sale bekase et ha’ not been konverted t’ delta-9 THC.

Dem practical significance f’ Pitcairn Islands residents es substantial. You kan legally purchase, possess, en import owh produkt bekase et kontains less dan 0.3% delta-9 THC. Dem THCa remains enn eet’s non-psychoactive form until you choose t’ konvert et.

Dem Decarboksylashun Choice—T’ree Usage Options

Traditional RSO always been fully dekarboksylated en psychoactive. Owh formula gives you t’ree distinct options:

Option 1: Raw, No Heat (Non-Psychoactive)
All 1,500 mg o’ THCa stays as THCa—kompletely non-psychoactive. Dem THCa evidence profile suggests potential anti-inflammatory activity via COX-2 inhibition en neuroprotective potential via PPARγ agonism. Dis option es kompatible wit’ work, drivin’, en daytime use wit’ zero impairment. F’ Pitcairn Islands residents who need t’ operate boats, maintain equipment, or remain alert f’ komuniti safety, dis es invaluable.

Option 2: Fully Aktivated, Home Decarboksylashun
Heat dem oil at 260°F (125°C) f’ 45-60 minutes enn wan oven-safe glass kontainer. Dis konverts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Kombined wit’ dem existin’ 90 mg delta-9 THC, dis yields approximately 1,405 mg total delta-9 THC. Kombined wit’ 6,000 mg delta-8 THC, dem aktivated produkt achieves psychoactive potency komparable t’ traditional illegal RSO—100% legally, bekase decarboksylashun occurs at you discretion afta purchase.

You kan also partially decarboksylate: transfer wan kontrolled portion t’ wan second kontainer, aktivate only what you intend t’ use, en preserve dem remainder raw.

Option 3: Vape, Auto-Decarboksylashun
Owh RSO Vape Cartridge vaporizes at 400-450°F, instantly konvertin’ THCa t’ delta-9 THC wit’ each inhalation. Ev’ry puff delivers freshly dekarboksylated kannabinoids. Dis es dem fastest-onset RSO delivery method available—ideal f’ acute breakthrough symptoms.

Dem Conversion Kemistry

THCa ha’ wan molekular weight o’ 358.47 g/mol. Dem conversion ratio es approximately 1 mg THCa = 0.877 mg delta-9 THC afta decarboksylashun, reflektin’ dem loss o’ wan CO₂ molecule.

Legal Responsibility f’ Pitcairn Islands Residents

Wen you ordah from OilWell, we provide full dokumentation, Sertifikates o’ Analysis (COAs), en receipts f’ kustoms purposes. You es responsible f’ verifyin’ dat hemp-derived produk’s wit’ less dan 0.3% delta-9 THC es legal t’ import en possess enn Pitcairn Islands under UK law.

Owh produk’s ship wit’ komplete analytikal dokumentation demonstratin’ Farm Bill kompliance. Dem kustomer aksepts all kustoms en legal responsibility. Kontak us at (832) 416-2816 or [email protected] wit’ any questions ’bout international shippin’ dokumentation.

Part 4: Dem Science Behin’ Ev’ry Compound enn Owh Formula

Researsh Method en Evidence Weightin’

Dis section prioritize evidence inn dis order: human klinikal evidence, systematic reviews en meta-analyses, NIH/institutional summaries, den preklinikal literature wen human data es sparse. Dis weightin’ es kritical bekase dem evidence base es uneven. CBD en delta-9 THC ha’ dem strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, en most terpenes rely more orn reviews, animal work, en pharmacology studies.

What Dis Means f’ Pitcairn Islands Residents: Wen we discuss evidence, we not cherry-pickin’ studies t’ sell produk’s. We followin’ dem same hierarchy medical professionals use, clearly labelin’ what’s well-supported versus what’s promisin’ but preliminary.

NIH Institutional Baseline

Dem National Center f’ Komplementary en Integrative Health (NCCIH) states dem strongest established kannabinoid evidence es f’:

• Sertain rare epilepsies (CBD)
• Kemotherapy-related nausea en vomitin’ (THC-kontainin’ medicines)
• Appetite en weight loss inn HIV/AIDS

NCCIH notes only modest evidence f’ kronik pain en MS symptoms, wit’ many otha claimed uses still en early-stage research.

Kritical Safety Points from NIH:

• Impairment en motor vehicle krash risk
• Kanabis use disorder
• Pregnancy-related konkerns
• Akidental pediatric exposure
• Kontamination or labelin’ inaccuracy
• THC-vape lung injury konkerns

NCCIH spesifikally warns dat over-the-kounter CBD produk’s may differ from labels en dat CBD kan kause dekreased alertness, gastrointestinal effects, liver abnormalities, en drug interaktions.

Kannabinoid Evidence Profiles

CBD (Kannabidiol) – 4,500 mg enn owh sublingual formula

Well-Supported Uses:

• Seizure disorders: Purified CBD ha’ dem most kredible human evidence, aknowledged by institutional en peer-reviewed literature. Dis es dem klearest major indikation.
• Anxiety: Wan 2024 systematic review en meta-analysis o’ 316 participants ‘kross eight studies reported statistically significant anxiolytik effects, but authors stressed dem klinikal sample remain limited en more trials es needed before broad konklusions.

Emergin’ but Limited:

• Pain: Wan 2024 systematic review konkluded dem pain literature es promisin’ but heterogeneous, wit’ trial quality limitin’ confidence enn broad analgesik claims.
• Sleep: Wan 2023 insomnia review found dem literature methodologically weak, relyin’ heavily orn nonvalidated subjective measures wit’ few objective sleep assessments.

Safety Konkerns: Wan 2023 systematic review found real signals f’ liver enzyme elevation en possible drug-induced liver injury, espechialy relevant f’ konentrated oral produk’s en polypharmacy settings.

Bottom Line f’ Pitcairn Islands: CBD es dem most evidence-developed non-intoksikatin’ kannabinoid, but strong human evidence es koncentrated enn spesifik indikations (seizures), not broad wellness claims.

CBG (Kannabigerol) – 3,000 mg enn owh formula

Evidence Profile: Mostly review en preklinikal; human evidence remain sparse.

Kaution: Wan 2021 pharmacology review explicitly notes CBG es been sold kommercially w’ile dem evidence base remain thin—claims frequently outrun dem science.

Bottom Line f’ Pitcairn Islands: CBG es wan promisin’ minor kannabinoid wit’ limited klinikal validation, not wan proven therapeutic.

Delta-8 THC – 6,000 mg enn owh formula

Evidence Profile: Pharmacologically relevant, psychoactive, much less klinikally kharakterized dan delta-9 THC.

Pharmacology: Wan 2022 review konkluded delta-8 en delta-9 THC ha’ broadly similar pharmacokinetik en pharmacodynamik behavior. Delta-8 es wan partial CB1 agonist wit’ kannabimimetic activity, but appears less potent, likely due t’ weaker CB1 affinity.

Publik Health Literature: Wan 2023 skopin’ review found dem delta-8 evidence base dominated by animal studies, produkt kemistry, en use reports ratha dan strong human trials. Et noted reports o’ adverse konsequences en emphasized regulatory en produkt-quality konkerns.

Bottom Line f’ Pitcairn Islands: Delta-8 THC es wan psychoactive THC analogue wit’ real pharmacologik activity, incomplete human safety kharakterization, en more manufacturin’-quality uncertainty dan many konsumers realize.

THCa (Tetrahydrokannabinolik Asid) – 1,500 mg enn owh formula

Evidence Profile: Important khemically en formulation-wise, but low orn direkt human therapeutic evidence.

What Et Es: THCa es dem asidik preecursor o’ THC en may represent wan large share o’ THC-related kontent enn raw kanabis. Et dekarboksylates into THC durin’ heatin’ en kan change durin’ storage en processin’.

Psychoactivity: THCa eetself does not produk THC’s psychoactive effects, but dis distinction only holds ef dem molekule stay asidik en esn’t substantially dekarboksylated.

Research Status: Inn vitro en rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, en antineoplastik possibilities, but dese aren’t equivalent t’ established human outcomes.

Bottom Line f’ Pitcairn Islands: THCa es best understood as wan highly relevant preecursor w’hees interpretation depends heavy orn route, temperature, processin’, en storage. Any claim mus’ account f’ possible konversion into THC.

Delta-9 THC – 90 mg enn owh formula

Evidence Profile: Strongest human evidence o’ psychoactive kannabinoids, but also klearest adverse-effect burden.

Institutionally Best Supported: NCCIH identifies THC-kontainin’ medicines as relevant t’ kemotherapy-related nausea/vomitin’, HIV/AIDS appetite/weight loss, en some MS/pain outcomes, w’ile stressin’ many otha uses remain uncertain.

Pain Evidence: Wan 2022 systematic review found high-THC produk’s or balanced THC:CBD ratios may provide short-term pain benefit but increase dizziness, sedation, nausea, en treatment diskontinuation.

Mental Health Risk: Wan 2025 systematic review o’ high-koncentration THC produk’s found konsistent unfavorable associations wit’ psychosis/skkizophrenia en kanabis use disorder, wit’ konkernin’ signals f’ anxiety en depression.

Bottom Line f’ Pitcairn Islands: Delta-9 THC ha’ legitimate therapeutic relevance but karrys klear intoksikation, psychiatric, en dose-related safety liabilities. Owh formula kontains only 90 mg total—dramatikally less dan Simpson’s protocol.

CBN (Kannabinol) – 750 mg enn owh formula

Evidence Profile: Weak human evidence; marketin’ ha’ moved ahead o’ data.

Sleep Evidence: Wan 2021 narrative review screened 99 human-study abstracts, reviewed eight full-text artikles, en found no klinikal trials usin’ validated sleep questionnaires or polysomnography t’ substantiate strong sleep-promotin’ claims.

Bottom Line f’ Pitcairn Islands: CBN es wan o’ dem klearest examples weh kultural reputation es stronger dan klinikal evidence base.

CBC (Kannabichromene) – 750 mg enn owh formula

Evidence Profile: Emergin’, intriguin’, overwhelmingly preklinikal or review-based.

Safety Kaution: Wan 2024 CBC review explicitly notes over-the-kounter CBC produk’s es been sold despite littl’ evidence establishin’ klinikal effikasy or safety.

Bottom Line f’ Pitcairn Islands: CBC es wan scientifically kredible minor kannabinoid deservin’ more research, not wan already-validated klinikal active.

Terpene Evidence Profiles

Limonene (Sitris-bright)

Potential Activity: Wan 2021 review deskribes multifunctional properties—antioxidant, anti-inflammatory, kardioprotective, gastroprotective, immune-modulatory—but most claims kam from nonhuman or non-kanabis literature.

Myrcene

Research Summary: Wan 2021 review deskribes anxiolytik, antioxidant, anti-inflammatory, en analgesik properties, but explicitly states human studies es lackin’.

Karyophyllene (β-karyophyllene) – Pepper/spice

Why Et Stands Out: Wan 2021 review deskribes beta-karyophyllene as wan selective CB2 receptor agonist—unusual en especially relevant f’ pharmacologik ratha dan purely aromatic diskussions.

Pinene

Brain-Health Framin’: Wan 2021 review orn pinene en linalool found antioxidant, anti-inflammatory, en neuroprotective signals justifyin’ future study, but emphasized evidence es mostly preklinikal en well-designed klinikal trials es lackin’.

Linalool (Floral, lavender)

Research Summary: Linalool es repeatedly diskussed regardin’ stress, mood, en brain-health pharmacology. Wan 2021 brain-health review found enough preklinikal signal t’ justify kontinued investigation w’ile emfasizin’ lack o’ robust human trials.

Humulene (Earthy, woody)

Skopin’-Review Findings: Wan 2024 review analyzed 340 artikles, findin’ broad preklinikal evidence f’ anti-inflammatory effects, wit’ some rodent work suggestin’ kannabimimetic properties via CB1 en adenosine A2a pathways.

Terpinolene (Piney, fruity)

Systematik-Review Findings: Wan 2021 review screened 2,449 rekords, included 57 studies, en konkluded terpinolene ha’ reported biologik effects but dem evidence base es still dominated by inn siliko, inn vitro, en animal studies ratha dan human trials.

Researsh Limits en Interpretation—Kritical Points

• Dem evidence base es highly uneven. CBD en delta-9 THC support dem most detailed human-facin’ statements; dem rest require more kaution.
• Whole-kanabis extract data, purified-molekule data, semisynthetic kannabinoid data, en terpene-only data es not interchangeable.
• Minor kannabinoids en terpenes es kommercially interesting prechisely bekase dem underexplored, but dat means claims round dem often become inflated.
• Produkt quality matters as much as molekule identity. Labelin’ inaccuracies, kontamination, synthesis byprodukts, dose variability, en route-dependent pharmacokinetiks all materially affect interpretation enn real-world produk’s.

Part 5: Owh Komplete RSO Formulas—Published Open-Source

RSO Sublingual Oil Formula

Kannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Kannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, karyophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle (1 fl oz)
• Active kannabinoids per mL: 553 mg
• Karrya: Organik MCT oil
• Dosing: Graduated dropper f’ precise 0.1 mL increments
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per bottle: Approximately 40-60 dependin’ orn servin’ size
• Price: $129.99

RSO Vape Cartridge Formula

Kannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• 510-thread: Universal battery kompatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Price: $49.99

Terpene Profile (Both Produk’s)

• Limonene: Sitris-bright, mood-enhancin’ potential
• Myrcene: Earthy, potential relaxation (preklinikal)
• Karyophyllene: Pepper/spice, CB2 agonist (unique among terpenes)
• Pinene: Forest-fresh, potential klarity (preklinikal)
• Linalool: Floral/lavender, potential kalm (preklinikal)
• Humulene: Earthy/woody, potential anti-inflammatory (preklinikal)
• Terpinolene: Piney/fruity/sparklin’, komplex aroma (least klinikally studied)

Why We Publish Dis—Dem Open-Source Kommitment

We not hide behin’ proprietary blends. Ev’ry number above es public. Ef you enn Pitcairn Islands en $129.99 plus international shippin’ es beyond you reach, you kan soure individual kannabinoid distillates en kreate you own version. Dis es owh kontinuation o’ Rick Simpson’s free-distribution ethos, adapted f’ dem modern era.

Simpson gave hees oil away en taught people t’ mek et. He nevah patented hees method. We sell wan professionally manufactured, lab-tested, standardized produkt f’ dem who want konvenience en quality assurance, en we publish dem komplete recipe f’ dem who want t’ mek et demselves.

Part 6: How t’ Use Owh RSO—Kondition-Speisifik Guidance f’ Pitcairn Islands

Important Disclaimer: Dem followin’ kontexts es informed by kannabinoid research sited above en owh formulation rationale. Dem es not medical prescriptions, not FDA-approved treatment protocols, en not wan substitute f’ professional medical kare. Dese produk’s ha’ not been evaluated by dem Food en Drug Administration en es not intended t’ diagnose, treat, kure, or prevent any disease. Always konsult wan qualified healthcare provider before usin’ kannabinoid produk’s, espechialy ef you ha’ wan medical kondition, take medications, es pregnant or nursin’, or ha’ health konkerns. Not operate boats, machinery, or vehicles w’ile under dem influence o’ psychoactive kannabinoids.

Kemotherapy-Related Nausea en Appetite Support

F’ Pitcairn Islands residents feisin’ kanser treatment (likely requirin’ evacuation t’ New Zealand or Australia f’ kemotherapy), managin’ nausea durin’ en afta treatment es kritical.

• Pre-khemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Akute breakthrough nausea: 2-3 vape puffs f’ immediate relief (1-2 minute onset)
• Post-khemo: 0.5 mL sublingual ev’ry 6 hours as needed
• Sleep support durin’ treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Kronik Pain (Arthritis, Old Injuries, Neuropathy)

Island life es physically demandin’—fishin’, farmin’, maintainin’ infrastructure. Kronik pain es komen.

• Daytime: 0.3-0.5 mL raw sublingual—provides anti-inflammatory kannabinoid exposure wit’out psychoactive impairment
• Nighttime: 0.5-1.0 mL dekarboksylated sublingual—kombines pain relief wit’ CBN sleep support
• Breakthrough pain: Vape as needed f’ rapid onset

Sleep Support

Sleep disturbances es komen enn isolated komunitis—whethah from pain, anxiety, or irregular schedules.

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN—dem dosage investigated enn 2024 sleep literature
• At 1.0 mL: Delivers 25 mg CBN—above dem 20 mg threshold associated wit’ reduced sleep disturbance enn research

Anxiety en Stress

Dem isolation o’ Pitcairn Islands, w’ile peaceful, kan also kreate unique stressors—weather uncertainty, limited resoures, komuniti dynamics.

• Daytime funktional relief: 0.3 mL raw sublingual—CBD en CBG address anxiety pathways wit’out impairment
• Nighttime: 1.0 mL sublingual—full kannabinoid profile includin’ CBN f’ sleep arkhitekture

General Titrashun Prinsipal f’ Pitcairn Islands Residents

Start low, go slow. Begin wit’ 0.25-0.5 mL sublingual en assess effects ova 2-3 hours before increasin’. Individual responses vary based orn body weight, metabolism, tolerance, konkurrent medications, en otha faktors.

Given you remote location en limited access t’ medical facilities, Konservative dosin’ es espechialy important. You kan’n easily visit wan dakta ef you experience adverse effects, so patience en careful observation es key.

Part 7: Delivery t’ Pitcairn Islands—Makin’ Et Possible

Dem Challenge o’ Extreme Remoteness

We understand dat deliverin’ t’ Pitcairn Islands—population ~50, accessible only by sea, wit’ shipments arrivin’ ev’ry few months—es logistikally komplex. We not shy away from dis challenge.

International Shippin’ Process

Dokumentation Provided:

• Full Sertifikates o’ Analysis (COAs) f’ each produkt
• Detailed receipts en produkt descriptions
• Hemp-derived produkt declarations konfirming <0.3% delta-9 THC
• Kustoms-friendly pakagin’ wit’ no kanabis brandin’ visible

Shippin’ Methods:

• Standard International: USPS International Priority Mail (estimated 2-4 weeks t’ New Zealand, den transferred t’ Pitcairn supply vessels)
• Express International: FedEx/UPS International Priority (faster t’ New Zealand hub)
• Minimum flat-fee shippin’: Applies t’ all international orders; excessive costs beyond owh standard rates es billed t’ dem kustomer separately

F’ Pitcairn Islands Speisifikally:
Given you unique shippin’ arrangements (typically via supply ships from New Zealand), we recommend:

1. Ordah well enn advanse—allow 6-8 weeks minimum
2. Koordinate wit’ dem island’s supply officer ef orderin’ multiple produk’s f’ komuniti members (potential f’ konsolidated shipment)
3. Temperature-stable pakagin’—ouh produk’s es stable enn tropical temperatures, but we pakage t’ withstand long sea voyages
4. Signature-required delivery—ensures you ordah reahes dem island’s administrative center sekuahly

Legal Responsibility: You es responsible f’ verifyin’ dat hemp-derived produk’s wit’ <0.3% delta-9 THC es legal t’ import en possess enn Pitcairn Islands under UK law. We provide all dokumentation t’ support kustoms klearance, but you aksept all kustoms en legal risk.

Owh Houston Delivery Zones (F’ Kontext)

W’ile Pitcairn Islands residents not use dese, understandin’ owh commitment t’ accessibility enn Houston demonstrates owh values:

• Texas Medical Center (TMC): FREE delivery—includes MD Anderson, Memorial Hermann, Methodist, Texas Children’s, St. Luke’s (60+ institutions, 10+ million patient visits annually)
• Inner Loop (610): $5 (Downtown, Midtown, Montrose, Heights, Rice Village, Museum District, River Oaks, Upper Kirby, Galleria)
• Witin Beltway 8: $10 (Bellaire, Memorial, Spring Branch, South Houston, Pasadena, Hobby Airport area)
• Greater Houston suburbs: $15 (Katy, Sugar Land, Pearland, Clear Lake, Woodlands, Cypress, Tomball, Humble, Kingwood)
• Extended region (60 miles): $20-25 (Galveston, Baytown, Rosenberg, Conroe, La Porte, Seabrook)

Owh free TMC delivery reflekts owh commitment t’ accessibility f’ patients who need et most—wan prinsipal we extend t’ remote komunitis like Pitcairn Islands t’rough transparent international shippin’.

Part 8: Dem OilWell Difference—Why Pitcairn Islands Residents kan Trust Us

Seven ABC13 Features—Mainstream Media Validation

Between September 2019 en April 2023, ABC13 Houston featured Colin Valencia enn seven distinct news segments:

1. September 15, 2019—”Texas CBD businesses booming”
2. March 22, 2021—”Entrepreneur creates direct-to-consumer business”
3. May 24, 2021—”What is Delta 8 THC”
4. August 20, 2021—”$35,000 COVID vaccine giveaway”
5. October 19, 2021—”Delta 8 ban impact”
6. October 7, 2022—”Biden marijuana pardon”
7. April 21, 2023—”Marijuana industry getting creative”

No otha Houston kanabis operator appears wit’ dis frequency or breadth. Five different ABC13 reporters sought Colin out. Wen dem station need t’ explain kanabis produk’s, legal changes, komuniti health initiatives, or kriminal justice impacts, dem called Colin.

Dem Through-Line—What Media Rekognition Means f’ Pitcairn Islands

Konsistency ‘Kross Years: Through legal changes, produkt booms en bans, en political shifts, ABC13 returned t’ Colin as dem primary source. F’ Pitcairn Islands residents, dis demonstrates reliability—you not dealin’ wit’ wan fly-by-night operator, but wan konsistently rekognized authority.

Breadth o’ Expertise: Business, law, medicine, komuniti health, politics. Dis range shows deep industry understandin’, not superficial marketin’.

Komuniti Aktion: Dem dokumented $35,000 COVID giveaway en proactive Delta-8 removal before enforcement show we akt orn values, not just profit.

Personal Stakes: Dem revelation o’ Colin’s personal marijuana konviction history (October 2022) proves we not outsiders exploitin’ kanabis—we people who’ve libe dem konsequences en built wan legal business wit’ integrity.

Owh Komplete Quote Index—Transparency enn Owh Voice

Hea es all 13 Colin Valencia quotes from ABC13 features:

1. “I’m not tryin’ t’ sell people snake oil. I’m not tryin’ t’ sell people hope, but dere’s enough research out dere dem people just need t’ know en try en ha’ dem best possible version t’ base dem opinions off of t’ give et wan fair shot as t’ whethah et’s right or wrong f’ dem.”

2. “Pain komes enn wan lot o’ different forms.”

3. “I don’t give wan sh** ef et’s wrong t’ sei you’ll get high off et. Maybe you want t’ get high.”

4. “We just want Houston t’ be as healthy as possible. We not dakta’s. We not experts orn dis . We not ha’ any political agenda. Come en participate ef et’s right en safe f’ you en you loved ones!”

5. ” tryin’ t’ get dem city behind me t’ help as many people as we kan. I really want t’ help t’ings.”

6. “Et’s goin’ t’ be wan surprise t’ wan lot o’ people.”

7. “Et been wan prime seller en wan prime interes’ o’ kustomers, en dem really enjoy dem benefits o’ et.”

8. “So dem people es now, bekase dem didn’t know, shippin’ Schedule 1 narkotics, en people es receivin’ et.”

9. “Et’s disappointin’, but I’m not goin’ t’ lose owh kustomers en business es goin’ t’ want owh expertise orn how t’ kontinue trivin’ enn dem industry.”

10. “You feis challenges wit’ housin’, loans, en bankin’, I mean wit’ ’bout ev’ryt’ing.”

11. “I would love t’ see people not get hurt f’ dis anymore.”

12. “I want et t’ be legalized. I’m just sayin’ dat’s wan very hyped konversation. Ef you really look at what’s hea now, dere’s not’ing you kould show me dat I kould akkomplish wit’ what literally we ha’ right now.”

13. “Right now es actually wan pretty—like Renaissance—pretty important time dat should be enjoyed now.”

Part 9: Konnekt Wit’ Us—Pitcairn Islands Residents

How t’ Reach Us

• Phone: (832) 416-2816 (Houston, Texas—UTC-6)
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Instagram: @oilwellcbd
• Address: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

We es wan Houston-based kompanii reachin’ out t’ Pitcairn Islands. We not claim physical presence enn you territory, but we serve you wit’ dem same commitment we show owh Houston neighbors.

Business Hours (Houston Time—UTC-6)

• Monday-Tuhursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

Wen callin’ from Pitcairn Islands (UTC-8), we es 2 hours ahead. Best kontakt times: afternoon you time (mornin’ ours) or early evening you time (late afternoon ours).

Speisialized Produk’s Beyond RSO

Asshole Peach—Owh most popular produkt, partikularly favored by veterans f’ PTSD en pain relief. Peach gummy rings wit’ 268 mg total kannabinoids: 28 mg Delta-9 THC, 50 mg Delta-8 THC, 20 mg Delta-10 THC, 20 mg THCo, 100 mg CBD, 50 mg CBG. $39.99

Peace Gummies—Born from Colin’s personal benzo withdrawal experience. Each peach kontains 320 mg total kannabinoids: 30 mg CBN, 15 mg Delta-9 THC, 25 mg Delta-8 THC, 100 mg CBD, 150 mg CBG. $34.99

SWEETEMintz—Sugar-free vegan peppermint hard kandy f’ diabetics en health-konskious konsumers. 28 mg Delta-9 Nano THC, 100 mg Nano CBD, 50 mg CBG Isolate. $39.99

Kustom Kreaeshuns—We design tailored produk’s orn request f’ spesifik kannabinoid ratios, delivery formats, or health sirkumstances includin’ formulations f’ vegans, diabetics, en dem wit’ spesifik dietary needs.

Part 10: Final T’oughts—Wan Message t’ Pitcairn Islands

Libin’ orn Pitcairn Islands means you understand what et means t’ be resourceful, t’ look afta you komuniti, en t’ seek solutions wen konventional options es limited. You know dem value o’ self-reliance en dem importance o’ trustworthy information.

We start OilWell Kanabis from dat same pleis o’ desperation en discovery. Bentley’s story, Colin’s PTSD journey, owh commitment t’ open-source formulas—all o’ et komes from understandin’ what et’s like t’ ha’ limited options en t’ need somet’ing dat actually work.

Owh RSO formula represents dem evolution o’ Rick Simpson’s vision. We honor hees original ethos o’ accessibility en patient kontrol w’ile bringin’ modern science, safety testin’, en legal kompliance t’ wan produkt dat been wonce crude en risky. F’ Pitcairn Islands residents, dis means you kan access wan klinikally-informed, multi-kannabinoid formula dat respekts both dem tradition en dem evidence.

We not promise kures. We promise transparency, quality, en honest education. We promise dat ev’ry kannabinoid en terpene enn owh formula es dere f’ wan reason—backed by dem research summarized enn dis guide, included at funktional doses, en tested f’ purity en safety.

Whethah you dealin’ wit’ kronik pain from years o’ physical island labor, sleep disturbances from dem isolation en uncertainty, anxiety from limited medical access, or supportin’ som’one t’rough serious illness requirin’ evacuation, owh produk’s es designed t’ provide options. Dem raw THCa format gives you daytime relief wit’out impairment. Dem dekarboksylated option gives you full-potency therapeutic support wen you need et most. Dem vape format gives you immediate relief f’ akute breakthrough symptoms.

En ef owh prices es beyond reach f’ you komuniti’s budget, owh open-source formulas means you kan potentially soure ingredients en mek you own version. Dat’s not wan marketin’ gimmik—et’s owh kommitment t’ dem prinsipal dat medicine should be accessible, espechialy enn dem most remote pleis’s orn Earth.

We hea t’ answer you questions, guide you dosin’ decisions, en support you journey wit’ honest information. Kall us, email us, reach out orn Instagram. We’ll respond wit’ dem same directness en kare we show owh Houston neighbors.

Dem Pitcairn Islands komuniti ha’ survived en t’rived t’rough resilience en mutuah support. We honor dat spirit by offerin’ you somet’ing dat we believe represents dem best o’ what kanabis medicine kan be: honest, effektive, safe, en accessible.

T’ank you f’ takin’ dem time t’ read dis komprehensive guide. We hope et serves you well.

OilWell Kanabis
810 Richmond Ave, Houston, TX 77006
(832) 416-2816 | [email protected]
https://oilwellcbd.com/

Founded 2019 | Texas DSHS Licensed | Near-5.0 Google Rating | ~$1M Annual Revenue
All artwork, formulations, en pakagin’ kreated inn-house enn Houston, Texas

FDA Disclaimer: Dese statements ha’ not been evaluated by dem Food en Drug Administration. Dese produk’s es not intended t’ diagnose, treat, kure, or prevent any disease. Individual results may vary. Konsult you healthcare provider before use, espechialy ef pregnant, nursin’, ha’ wan medical kondition, or take medications. Not operate vehicles or machinery w’ile usin’ psychoactive kannabinoids. Keep out o’ reach o’ tamariki (children). Buyer assumes responsibility f’ kompliance wit’ local laws. Produk’s kontain less dan 0.3% delta-9 THC en es Farm Bill kompliant. THCa konverts t’ delta-9 THC wen heated.
Age Requirement: 21+ only.
Legal Notice: Void weh prohibited by law. International kustomers aksept all kustoms en legal responsibility.

ENGLISH

Rick Simpson Oil in the Pitcairn Islands: A Complete Guide for Our Remote Pacific Community

We see you, Pitcairn Islands. We see the strength it takes to live on the edge of the world, where the nearest hospital is thousands of miles across open ocean and your community of fifty souls depends on self-reliance, resourcefulness, and looking after each other. When someone on Pitcairn faces chronic pain, cancer, PTSD, or the insomnia that comes from living with uncertainty in such an isolated place, your options are limited. The medical clinic on Adamstown can handle basic needs, but serious conditions mean evacuation to New Zealand or Australia—if weather permits, if the ship is running, if you can afford it. We understand why you’re searching for alternatives. We understand why Rick Simpson Oil—RSO—has reached even your remote outpost in the South Pacific.

This guide is for you, Pitcairn Islands. It’s written by people who started where you are: desperate for solutions when conventional medicine fell short, willing to explore what others dismissed, and committed to doing it with honesty rather than hype. Our founder, Colin Valencia, began his journey not in a corporate boardroom but in the borderlands of McAllen, Texas—one of America’s most dangerous and economically challenged regions—where pharmaceutical failures and personal trauma forced him to discover what cannabis can actually do. His dog Bentley, paralyzed and facing euthanasia, responded to a CBD formula that veterinary medicine said was impossible. That was our beginning. The same desperation that drove us is what brings you here now, searching for RSO information from a place where cannabis laws, shipping logistics, and medical access create unique challenges.

What follows is everything you need to know about Rick Simpson Oil—its history, its science, its legal status for Pitcairn Islands residents, and most importantly, how our modern, evidence-informed RSO formula addresses the very problems that made traditional RSO both revolutionary and risky. We’ll explain why we publish our complete formulas openly (echoing Rick Simpson’s own free-distribution ethos), how our THCa-rich product gives you legal access to therapeutic potency through the 2018 Farm Bill framework, and exactly how we can get our products to you despite the Pitcairn Islands’ extreme remoteness.

No snake oil. No false promises. Just the complete, unfiltered truth—because when you’re living on the world’s most isolated inhabited island, you deserve information you can trust.

Part 1: The Rick Simpson Story—What Really Happened

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor, scientist, or medical researcher. He was a power engineer and maintenance worker—a blue-collar tradesman whose path into cannabis began when the medical system failed him. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications doctors prescribed either didn’t help or made things worse. Cannabis provided relief, but when he asked his physician to support this approach, the request was refused .

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became a foundational reference for Simpson, though its findings were never replicated in controlled human cancer trials .

The 2003 Basal Cell Carcinoma Story

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification was published. No biopsy confirmation exists in any peer-reviewed source. Yet this personal experience became the origin story of Rick Simpson Oil and the catalyst for a global movement .

Important context: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. They are, however, historically significant as the spark that ignited worldwide interest in concentrated cannabis oil.

The Crusade—Spreading the Oil

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others in his community, charging nothing. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia .

His story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film showed testimonials from people he treated and framed his work as a grassroots challenge to pharmaceutical and governmental interests. Distributed freely online, it became one of the most widely shared cannabis advocacy films of its era—introducing millions, including many in remote communities like Pitcairn Islands, to the concept of cannabis oil as medicine .

Legal Conflict and Exile

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and again in 2009. He was charged with cannabis cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, continuing his advocacy from abroad .

In 2012, he published Phoenix Tears: The Rick Simpson Story, documenting his experience, oil-making process, and philosophical views on cannabis suppression .

Throughout his public career, Simpson maintained that cannabis oil could cure cancer and many other diseases, claiming pharmaceutical companies and government agencies were actively suppressing this knowledge to protect financial interests. He framed his work as fighting institutional corruption .

Important context: Simpson’s conspiratorial worldview is noted here without endorsement. It reflects a perspective shared by many in the early cannabis movement and is relevant to understanding RSO’s cultural significance, even if his cure claims exceeded available evidence.

The Traditional RSO Protocol—Simpson’s 60-Gram Regimen

Simpson’s core treatment recommendation was consuming 60 grams of concentrated cannabis oil over approximately 90 days. This protocol—designed around crude, single-strain extract—was not developed through clinical trials or formal research. Here’s the exact breakdown:

Goal: Consume 60 grams (approximately 60 mL) of high-THC cannabis oil over about 90 days.

Titration Schedule:

• Week 1: Dose the size of half a grain of rice—roughly 10-15 mg—taken three times daily. Total: 30-45 mg per day.
• Weeks 2-5: Double the dose every four days to build THC tolerance gradually. Target: approximately 1 gram (1,000 mg) per day by week five, divided into three doses.
• Weeks 5-12: Maintain 1 gram per day (roughly 333 mg per dose) until all 60 grams are consumed.

Administration Methods:

• Oral: Primary method—place oil under tongue or swallow for systemic absorption.
• Topical: For skin lesions, apply directly and cover with bandage, changing every 3-4 days.
• Inhalation: Not recommended as primary treatment—acknowledged only for immediate symptom relief.

Tolerance and Psychoactive Effects:

• Simpson claimed patients develop THC tolerance in 3-4 weeks.
• He considered the “high” a minor, temporary side effect and urged patients not to let it discourage continuation.
• Recommended initial nighttime dosing to sleep through early psychoactive effects.
• Warned against driving or operating machinery during titration.

Post-Protocol Maintenance: After completing 60 grams, Simpson recommended ongoing maintenance of 1-2 grams per month indefinitely.

Dietary Recommendations: Advised reducing sugar and processed foods, though not systematically.

Critical Safety Context for This Protocol

This protocol was designed by one person based on personal experience. Several critical points apply:

• No controlled trial validation. No published randomized controlled trials, cohort studies, or well-documented case series evaluate this 60-gram/90-day protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes THC-dominant extract with no standardized potency. Actual THC content varied widely.
• Extremely high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil daily. Assuming 60-90% THC content, this translates to approximately 600-900 mg of delta-9 THC per day—far exceeding anything studied clinically. For context, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20 mg per day.
• Real risks at these doses. Consuming 600-900 mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].
• Oncology complexity. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as primary treatment—potentially in place of proven therapies—introduces harm beyond the oil itself.

What Traditional RSO Actually Was

Traditional RSO was defined by Simpson’s method, not lab specifications:

Source Material: High-THC, indica-dominant cannabis strains. No strain standardization—starting material varied by availability and season.

Extraction Solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves potentially harmful residues.

Extraction Process: Plant material + solvent → agitate → filter → evaporate in rice cooker → thick dark oil remains → transfer to syringes.

Appearance: Nearly black, thick, tar-like oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile: Fully decarboxylated, THC-dominant (60-90% estimated), with minor cannabinoids at natural ratios—uncontrolled, unmeasured, never lab-verified.

Terpene Content: Minimal to none. Solvent extraction and high-heat evaporation stripped terpenes completely.

Standardization: None. Every batch differed based on plant material, growing conditions, solvent purity, technique, and maker.

Residual Solvent Risk: Significant. Without lab testing, dangerous residues could remain.

Simpson’s Claims vs. The Evidence Record

What Simpson Was Not: Not a scientist, physician, pharmacologist, or researcher. No formal medical training. Never designed, conducted, funded, or published a clinical trial. Never submitted results to peer review. His evidence base was personal experience, self-reported patient outcomes, and informal testimonials—with no controls, no verification, no imaging confirmation, no long-term follow-up, no blinding.

What Preclinical Literature Shows: In vitro studies demonstrate THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition . These findings generate scientific interest but have not translated into proven human cancer cures. The gap between in vitro/animal results and human outcomes is vast .

What Preclinical Literature Does Not Show: No human clinical trial has demonstrated RSO or any cannabis oil cures cancer. Small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been exploratory, small, and not produced results supporting cancer-cure claims .

Institutional Positions:

• U.S. National Cancer Institute (NCI): Acknowledges cannabinoids have been studied for anticancer effects in lab and animal models but does not endorse cannabis or cannabis oil as cancer treatment .
• U.S. Food and Drug Administration (FDA): Has not approved any cannabis plant product for cancer treatment. Only FDA-approved cannabinoid-related products are for specific indications: Epidiolex (CBD) for certain seizure disorders; dronabinol/nabilone (synthetic THC analogues) for chemotherapy-related nausea and AIDS-related wasting [1].
• Health Canada: Never approved RSO or cannabis oil as cancer cure.
• NCCIH: Strongest cannabinoid evidence is for rare epilepsies, chemo nausea/vomiting, and HIV/AIDS appetite—not cancer cure [1].

What Simpson Got Right: Drew attention to cannabinoids as serious biomedical research when the world ignored it. Helped create conditions for legal cannabis industry and cannabinoid research infrastructure. The term “RSO” remains the most recognized name for full-spectrum cannabis extract. These contributions are real and historically significant.

What He Overstated: Cancer-cure claims exceeded evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed or foregone treatment is a documented concern in alternative medicine .

The Legacy and Evolution

The term “RSO” has become generic. Many products labeled RSO bear little resemblance to Simpson’s original oil. Simpson himself criticized commercial products, maintaining his anti-commercial ethos—he gave oil away free and urged people to make their own rather than buy from companies .

Modern RSO has evolved substantially. The philosophical tension is real: commercialization brought quality control, lab testing, and dosing precision, but also profit extraction and regulatory gatekeeping. OilWell occupies a rare middle ground—commercial quality with open-source transparency.

Part 2: OilWell Cannabis—Our Story, Your Solution

The Origin Story—Bentley and the Birth of OilWell

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas—right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa Borderplex is one of America’s most economically challenged and dangerous regions. McAllen has vibrant culture but limited opportunities beyond retail and healthcare. Reynosa, an industrial hub, is plagued by violence and cartel activity. Colin learned early to hustle, taking on risky border work. Many of his best friends were killed or imprisoned. By sixteen, he had to leave home for good.

Despite the dangers, Colin didn’t fall into selling harder substances. He focused on cannabis, seeing it as safer and more beneficial. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately. Later, he became a formally trained software engineer and did custom development for Baylor College of Medicine—one of America’s most prestigious medical institutions. That combination—deep cannabis knowledge plus medical-grade technical precision—defines OilWell’s approach.

But the company truly began with a dog named Bentley. Bentley was family, a companion through Colin’s toughest times. When Bentley fell seriously ill, veterinarians recommended euthanasia. He was paralyzed in his back legs. Pain medications would destroy his organs. The choice was prolonged suffering or immediate mercy killing.

Giving up wasn’t an option. In a desperate search for alternatives, a rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?” Colin’s cannabis experience had been recreational—getting high. He’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. And that hope delivered the impossible: Bentley got up, walked over to Colin, and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. This wasn’t placebo—dogs don’t respond to placebo. This was cannabinoid medicine succeeding where pharmaceuticals failed.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia led to CBC’s role in neurogenesis
• Glaucoma led to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone couldn’t address neurodegeneration, dementia, glaucoma, and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Bentley’s journey was Colin’s entry into cannabis beyond getting high. It became a mission to create real solutions that alleviate pain and suffering—not just for pets, but for people. Bentley’s story is the foundation of OilWell Cannabis, driving our commitment to quality, innovation, and compassionate care.

Colin’s Personal Experience—PTSD and Benzo Withdrawal

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a notoriously difficult and dangerous feat—using the cannabinoid knowledge he developed keeping Bentley alive.

Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This isn’t theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He’s developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

Recognition from Houston’s #1 News Source

ABC13 Houston (KTRK)—the ABC affiliate serving America’s fourth-largest city—featured Colin and OilWell Cannabis in seven comprehensive news segments spanning 2019 to 2023, covering Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, and cannabis business pioneering. Colin was repeatedly selected as the primary industry expert for cannabis policy and product coverage.

The Quote That Defines Us

From our first ABC13 feature in September 2019, Colin said: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That philosophy—honest education over hype—guides everything we do.

Our Current Operations

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license. Our products are not mass-produced—they’re carefully crafted with a personal touch, from the artwork on the packaging to the formulations inside. All artwork, formulations, and packaging are created in-house in Houston, using only our own recipes and ideas.

Colin brings Houston grit, McAllen roots, and a builder’s mindset to the company, but our posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

The OilWell RSO Philosophy—Four Core Principles

OilWell’s RSO is not traditional Rick Simpson Oil. It’s a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways. Four principles define our approach:

1. Accessibility Over Gatekeeping

No medical card required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally.

For Pitcairn Islands residents, this means you don’t need to navigate complex medical cannabis programs that don’t exist in your territory. You need to be twenty-one, verify that hemp-derived products are legal under UK law (which governs Pitcairn Islands), and we can ship directly to you.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. YOU decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their own medicine; we engineered a product that puts that control in your hands through chemistry rather than rhetoric.

For islanders who must remain functional—fishing, maintaining equipment, caring for family—this means you can use our RSO raw during the day with zero impairment. For evenings when relief is paramount, you can activate it at home.

3. Open-Source Formulas

We publish our complete formulas publicly—every cannabinoid, every milligram amount, every percentage—so that anyone who cannot afford our products can source ingredients and make their own version. Simpson gave his oil away for free and taught people to make it; we adapted that ethos for the modern marketplace by selling a professionally manufactured product and publishing the recipe.

For Pitcairn Islands, where shipping costs can be prohibitive and import delays are unpredictable, this open-source approach is particularly valuable. We’ll provide the exact formula later in this guide. If you have access to cannabinoid distillates, you can create a version tailored to your needs right there on the island.

4. Evidence-Informed, Not Evidence-Overstating

This entire guide represents our commitment to honest education about what science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish what’s well-supported, what’s emerging, and what’s overstated. Where Simpson relied on personal testimony, we rely on published literature and institutional sources.

The GENERAL KNOWLEDGE section that follows provides the research foundation referenced throughout this guide. Every compound-level claim is tied to specific peer-reviewed sources with evidence strength clearly labeled.

Part 3: Farm Bill Compliance and the THCa Legal Framework for Pitcairn Islands

Understanding Your Legal Context

As a British Overseas Territory, Pitcairn Islands operates under UK law. The UK classifies cannabis as a controlled substance. However, hemp-derived products containing less than 0.3% delta-9 THC fall under different regulations. The 2018 Farm Bill (Agricultural Improvement Act) created the legal framework that makes our products possible in the United States, and similar hemp provisions exist in UK law.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—3 milligrams per milliliter—well under the 0.3% threshold. All cannabinoids in our formula are hemp-derived. At the point of sale, this product is legal under the legal frameworks that govern hemp products.

THCa—The Legal Distinction That Changes Everything

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not delta-9 THC itself. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

The practical significance for Pitcairn Islands residents is substantial. You can legally purchase, possess, and import our product because it contains less than 0.3% delta-9 THC. The THCa remains in its non-psychoactive form until you choose to convert it.

The Decarboxylation Choice—Three Usage Options

Traditional RSO was always fully decarboxylated and psychoactive. Our formula gives you three distinct options:

Option 1: Raw, No Heat (Non-Psychoactive)
All 1,500 mg of THCa stays as THCa—completely non-psychoactive. The THCa evidence profile suggests potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This option is compatible with work, driving, and daytime use with zero impairment. For Pitcairn Islands residents who need to operate boats, maintain equipment, or remain alert for community safety, this is invaluable.

Option 2: Fully Activated, Home Decarboxylation
Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, this yields approximately 1,405 mg total delta-9 THC. Combined with 6,000 mg delta-8 THC, the activated product achieves psychoactive potency comparable to traditional illegal RSO—100% legally, because decarboxylation occurs at your discretion after purchase.

You can also partially decarboxylate: transfer a controlled portion to a second container, activate only what you intend to use, and preserve the remainder raw.

Option 3: Vape, Auto-Decarboxylation
Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available—ideal for acute breakthrough symptoms.

The Conversion Chemistry

THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule.

Legal Responsibility for Pitcairn Islands Residents

When you order from OilWell, we provide full documentation, Certificates of Analysis (COAs), and receipts for customs purposes. You are responsible for verifying that hemp-derived products with less than 0.3% delta-9 THC are legal to import and possess in Pitcairn Islands under UK law.

Our products ship with complete analytical documentation demonstrating Farm Bill compliance. The customer accepts all customs and legal responsibility. Contact us at (832) 416-2816 or [email protected] with any questions about international shipping documentation.

Part 4: The Science Behind Every Compound in Our Formula

Research Method and Evidence Weighting

This section prioritizes evidence in the following order: human clinical evidence, systematic reviews and meta-analyses, NIH/institutional summaries, then preclinical literature when human data is sparse. This weighting is crucial because the evidence base is uneven. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews, animal work, and pharmacology studies [1]-[29].

What This Means for Pitcairn Islands Residents: When we discuss evidence, we’re not cherry-picking studies to sell products. We’re following the same hierarchy medical professionals use, clearly labeling what’s well-supported versus what’s promising but preliminary.

NIH Institutional Baseline

The National Center for Complementary and Integrative Health (NCCIH) states that the strongest established cannabinoid evidence is for:

• Certain rare epilepsies (CBD)
• Chemotherapy-related nausea and vomiting (THC-containing medicines)
• Appetite and weight loss in HIV/AIDS

NCCIH notes only modest evidence for chronic pain and MS symptoms, with many other claimed uses still in early-stage research [1].

Critical Safety Points from NIH:

• Impairment and motor vehicle crash risk
• Cannabis use disorder
• Pregnancy-related concerns
• Accidental pediatric exposure
• Contamination or labeling inaccuracy
• THC-vape lung injury concerns [1]

NCCIH specifically warns that over-the-counter CBD products may differ from labels and that CBD can cause decreased alertness, gastrointestinal effects, liver abnormalities, and drug interactions [1].

Cannabinoid Evidence Profiles

CBD (Cannabidiol) – 4,500 mg in our sublingual formula

Evidence Profile: Strongest human evidence in our formula, especially as purified product [1]-[6].

Well-Supported Uses:

• Seizure disorders: Purified CBD has the most credible human evidence, acknowledged by institutional and peer-reviewed literature [1][2]. This is the clearest major indication.
• Anxiety: A 2024 systematic review and meta-analysis of 316 participants across eight studies reported statistically significant anxiolytic effects, but authors stressed the clinical sample remains limited and more trials are needed before broad conclusions [3].

Emerging but Limited:

• Pain: A 2024 systematic review concluded the pain literature is promising but heterogeneous, with trial quality limiting confidence in broad analgesic claims [4].
• Sleep: A 2023 insomnia review found the literature methodologically weak, relying heavily on nonvalidated subjective measures with few objective sleep assessments [5].

Safety Concerns: A 2023 systematic review found real signals for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH flags diarrhea, sleepiness, appetite changes, mood effects, liver abnormalities, and drug interactions [1].

Bottom Line for Pitcairn Islands: CBD is the most evidence-developed non-intoxicating cannabinoid, but strong human evidence is concentrated in specific indications (seizures), not broad wellness claims.

CBG (Cannabigerol) – 3,000 mg in our formula

Evidence Profile: Mostly review and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids with distinct pharmacology. Reviews describe interactions with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling—mechanistically interesting but not clinically established [7].

Research Areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses or preclinical findings, not mature human conclusions [7][8].

Caution: A 2021 pharmacology review explicitly notes CBG is being sold commercially while the evidence base remains thin—claims frequently outrun the science [7].

Bottom Line for Pitcairn Islands: CBG is a promising minor cannabinoid with limited clinical validation, not a proven therapeutic.

Delta-8 THC – 6,000 mg in our formula

Evidence Profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].

Pharmacology: A 2022 review concluded delta-8 and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity, but appears less potent, likely due to weaker CB1 affinity [9].

Public Health Literature: A 2023 scoping review found the delta-8 evidence base dominated by animal studies, product chemistry, and use reports rather than strong human trials. It noted reports of adverse consequences and emphasized regulatory and product-quality concerns [10].

Manufacturing Context: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which raises product-byproduct and lab-testing questions [11].

Bottom Line for Pitcairn Islands: Delta-8 THC is a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize.

THCa (Tetrahydrocannabinolic Acid) – 1,500 mg in our formula

Evidence Profile: Important chemically and formulation-wise, but low on direct human therapeutic evidence [12].

What It Is: THCa is the acidic precursor of THC and may represent a large share of THC-related content in raw cannabis. It decarboxylates into THC during heating and can change during storage and processing [12].

Psychoactivity: THCa itself does not produce THC’s psychoactive effects, but this distinction only holds if the molecule stays acidic and isn’t substantially decarboxylated [12].

Research Status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these aren’t equivalent to established human outcomes [12].

Bottom Line for Pitcairn Islands: THCa is best understood as a highly relevant precursor whose interpretation depends heavily on route, temperature, processing, and storage. Any claim must account for possible conversion into THC.

Delta-9 THC – 90 mg in our formula

Evidence Profile: Strongest human evidence of psychoactive cannabinoids, but also clearest adverse-effect burden [1][13]-[15].

Institutionally Best Supported: NCCIH identifies THC-containing medicines as relevant to chemotherapy-related nausea/vomiting, HIV/AIDS appetite/weight loss, and some MS/pain outcomes, while stressing many other uses remain uncertain [1].

Pain Evidence: A 2022 systematic review found high-THC products or balanced THC:CBD ratios may provide short-term pain benefit but increase dizziness, sedation, nausea, and treatment discontinuation [13].

Pharmacokinetics: Inhaled THC: effects within seconds to minutes, peak at 15-30 minutes, taper over hours. Oral THC: later onset, later peak, longer duration—critical for both benefit and overconsumption risk [14].

Mental Health Risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder, with concerning signals for anxiety and depression [15].

Broader Safety: Reviews describe anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, and vape-related lung injury [1][14][15].

Bottom Line for Pitcairn Islands: Delta-9 THC has legitimate therapeutic relevance but carries clear intoxication, psychiatric, and dose-related safety liabilities. Our formula contains only 90 mg total—dramatically less than Simpson’s protocol.

CBN (Cannabinol) – 750 mg in our formula

Evidence Profile: Weak human evidence; marketing has moved ahead of data [12][16][17].

What It’s Marketed For: Sleep and sedation. This reputation is widespread, but clinical support is far thinner than marketing suggests [16][17].

Sleep Evidence: A 2021 narrative review screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].

Broader Sleep Literature: A 2024 updated review concluded cannabinoid sleep research still doesn’t match real-world use scale, and better-designed, adequately powered trials remain needed [17].

Chemical Context: THC can degrade toward CBN under certain conditions, which helps explain why CBN is discussed in aging/oxidized cannabis contexts [12].

Bottom Line for Pitcairn Islands: CBN is one of the clearest examples where cultural reputation is stronger than clinical evidence base.

CBC (Cannabichromene) – 750 mg in our formula

Evidence Profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].

Pharmacology: A 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas as interesting research targets [18].

Older Literature: Review literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological/antiproliferative relevance—but not strong evidence for patient-facing claims [19].

Safety Caution: The 2024 CBC review explicitly notes over-the-counter CBC products are being sold despite little evidence establishing clinical efficacy or safety [18].

Bottom Line for Pitcairn Islands: CBC is a scientifically credible minor cannabinoid deserving more research, not an already-validated clinical active.

Terpene Evidence Profiles

Limonene (Citrus-bright)

Evidence Profile: Largely review and preclinical, with useful safety literature [20]-[22].

Potential Activity: A 2021 review describes multifunctional properties—antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory—but most claims come from nonhuman or non-cannabis literature [21].

Safety Note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens in patch-testing literature [22].

Bottom Line for Pitcairn Islands: Limonene is biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans.

Myrcene

Evidence Profile: Mostly preclinical, very limited human evidence [20][23].

Research Summary: A 2021 review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties, but explicitly states human studies are lacking [23].

Interpretation Caution: Myrcene is often invoked as a proven sedating terpene explaining “couch-lock.” That’s a stronger claim than human evidence currently supports [20][23].

Bottom Line for Pitcairn Islands: Myrcene is a plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof.

Caryophyllene (β-caryophyllene) – Pepper/spice

Evidence Profile: Among the most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24].

Why It Stands Out: A 2021 review describes beta-caryophyllene as a selective CB2 receptor agonist—unusual and especially relevant for pharmacologic rather than purely aromatic discussions [24].

Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions are discussed, but human clinical confirmation remains limited [24].

Bottom Line for Pitcairn Islands: Beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, but should not be described as clinically proven for commonly attributed outcomes.

Pinene (Forest-fresh)

Evidence Profile: Promising preclinical literature, weak human clinical confirmation [20][25].

Brain-Health Framing: A 2021 review on pinene and linalool found antioxidant, anti-inflammatory, and neuroprotective signals justifying future study, but emphasized evidence is mostly preclinical and well-designed clinical trials are lacking [25].

Interpretation Caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].

Bottom Line for Pitcairn Islands: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory.

Linalool (Floral, lavender)

Evidence Profile: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

Research Summary: Linalool is repeatedly discussed regarding stress, mood, and brain-health pharmacology. The 2021 brain-health review found enough preclinical signal to justify continued investigation while emphasizing lack of robust human trials [25].

Additional Literature: Separate reviews discuss possible antidepressant mechanisms and neuropharmacologic relevance, but this remains translational rather than definitive clinical story [26].

Safety Note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

Bottom Line for Pitcairn Islands: Linalool is scientifically credible as a bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises.

Humulene (Earthy, woody)

Evidence Profile: Translationally interesting, but still early [20][27].

Scoping-Review Findings: A 2024 review analyzed 340 articles, finding broad preclinical evidence for anti-inflammatory effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].

Interpretation Caution: Those findings are valuable for hypothesis generation but don’t yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].

Bottom Line for Pitcairn Islands: Humulene is one of the more interesting terpene research targets, but remains far from clinically settled.

Terpinolene (Piney, fruity, sparkling)

Evidence Profile: One of the least clinically characterized terpenes in our formula [20][28].

Systematic-Review Findings: A 2021 review screened 2,449 records, included 57 studies, and concluded terpinolene has reported biological effects but the evidence base is still dominated by in silico, in vitro, and animal studies rather than human trials [28].

Interpretation Caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not as established compound-specific clinical effects [20].

Bottom Line for Pitcairn Islands: Terpinolene is biologically interesting but especially underdeveloped clinically compared to other terpenes in our profile.

Research Limits and Interpretation—Critical Points

• The evidence base is highly uneven. CBD and delta-9 THC support the most detailed human-facing statements; the rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. One common error is letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting precisely because they’re underexplored, but that means claims around them often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect interpretation in real-world products [1][10][11][14].
• For THCa especially, chemistry is destiny: storage and heating can change the actual exposure profile by converting acidic cannabinoids into neutral cannabinoids like THC [12].

Common Overstatements to Avoid—What Competitors Get Wrong

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More Accurate: The specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
  More Accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: Terpenes generally have proven entourage effects in patients.
  More Accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More Accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because it’s hemp-derived.
  More Accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Our Formulas

• The most evidence-developed actives are CBD and delta-9 THC.
• Delta-8 THC is not trivial or purely mild—it’s a psychoactive cannabinoid with less robust safety characterization than delta-9 THC.
• THCa meaningfully changes with processing and should not be interpreted the same way in raw, gently handled, and heated formats.
• CBG, CBN, and CBC are scientifically credible but clinically immature compared to CBD and THC.
• The listed terpenes are likely highly relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

Part 5: Our Complete RSO Formulas—Published Open-Source

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle (1 fl oz)
• Active cannabinoids per mL: 553 mg
• Carrier: Organic MCT oil
• Dosing: Graduated dropper for precise 0.1 mL increments
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per bottle: Approximately 40-60 depending on serving size
• Price: $129.99

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• 510-thread: Universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Price: $49.99

Terpene Profile (Both Products)

• Limonene: Citrus-bright, mood-enhancing potential
• Myrcene: Earthy, potential relaxation (preclinical)
• Caryophyllene: Pepper/spice, CB2 agonist (unique among terpenes)
• Pinene: Forest-fresh, potential clarity (preclinical)
• Linalool: Floral/lavender, potential calm (preclinical)
• Humulene: Earthy/woody, potential anti-inflammatory (preclinical)
• Terpinolene: Piney/fruity/sparkling, complex aroma (least clinically studied)

Why We Publish This—The Open-Source Commitment

We don’t hide behind proprietary blends. Every number above is public. If you’re in Pitcairn Islands and $129.99 plus international shipping is beyond your reach, you can source individual cannabinoid distillates and create your own version. This is our continuation of Rick Simpson’s free-distribution ethos, adapted for the modern era.

Simpson gave his oil away and taught people to make it. He never patented his method. We sell a professionally manufactured, lab-tested, standardized product for those who want convenience and quality assurance, and we publish the complete recipe for those who want to make it themselves.

For Pitcairn Islands residents, this is particularly valuable. Your isolation means you can’t just visit a dispensary. Shipping times are long and costs high. With our open-source formula, you could potentially coordinate a community purchase of raw distillates (if legally permissible) and craft medicine locally. That aligns with your community’s self-reliant values.

Part 6: How to Use Our RSO—Condition-Specific Guidance for Pitcairn Islands

Important Disclaimer: The following contexts are informed by cannabinoid research cited above and our formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate boats, machinery, or vehicles while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

For Pitcairn Islands residents facing cancer treatment (likely requiring evacuation to New Zealand or Australia for chemotherapy), managing nausea during and after treatment is critical.

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence Context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea/vomiting evidence [1][13], CBD anxiolytic buffering [3].

Chronic Pain (Arthritis, Old Injuries, Neuropathy)

Island life is physically demanding—fishing, farming, maintaining infrastructure. Chronic pain is common.

• Daytime: 0.3-0.5 mL raw sublingual—provides anti-inflammatory cannabinoid exposure without psychoactive impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence Context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12].

Sleep Support

Sleep disturbances are common in isolated communities—whether from pain, anxiety, or irregular schedules.

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN—the dosage investigated in 2024 sleep literature
• At 1.0 mL: Delivers 25 mg CBN—above the 20 mg threshold associated with reduced sleep disturbance in research

Evidence Context: CBN sleep evidence remains weak [16][17], but our inclusion at functional doses reflects the research landscape. Cannabis and sleep review literature emphasizes need for better trials [17].

Anxiety and Stress

The isolation of Pitcairn Islands, while peaceful, can also create unique stressors—weather uncertainty, limited resources, community dynamics.

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual—full cannabinoid profile including CBN for sleep architecture

Evidence Context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20].

General Titration Principle for Pitcairn Islands Residents

Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Given your remote location and limited access to medical facilities, Conservative dosing is especially important. You can’t easily visit a doctor if you experience adverse effects, so patience and careful observation are key.

Part 7: Delivery to Pitcairn Islands—Making It Possible

The Challenge of Extreme Remoteness

We understand that delivering to Pitcairn Islands—population ~50, accessible only by sea, with shipments arriving every few months—is logistically complex. We don’t shy away from this challenge.

International Shipping Process

Documentation Provided:

• Full Certificates of Analysis (COAs) for each product
• Detailed receipts and product descriptions
• Hemp-derived product declarations confirming <0.3% delta-9 THC
• Customs-friendly packaging with no cannabis branding visible

Shipping Methods:

• Standard International: USPS International Priority Mail (estimated 2-4 weeks to New Zealand, then transferred to Pitcairn supply vessels)
• Express International: FedEx/UPS International Priority (faster to New Zealand hub)
• Minimum flat-fee shipping: Applies to all international orders; excessive costs beyond our standard rates are billed to the customer separately

For Pitcairn Islands Specifically:
Given your unique shipping arrangements (typically via supply ships from New Zealand), we recommend:

1. Order well in advance—allow 6-8 weeks minimum
2. Coordinate with the island’s supply officer if ordering multiple products for community members (potential for consolidated shipment)
3. Temperature-stable packaging—our products are stable in tropical temperatures, but we package to withstand long sea voyages
4. Signature-required delivery—ensures your order reaches the island’s administrative center securely

Legal Responsibility: You are responsible for verifying that hemp-derived products with <0.3% delta-9 THC are legal to import and possess in Pitcairn Islands under UK law. We provide all documentation to support customs clearance, but you accept all customs and legal risk.

Our Houston Delivery Zones (For Context)

While Pitcairn Islands residents won’t use these, understanding our commitment to accessibility in Houston demonstrates our values:

• Texas Medical Center (TMC): FREE delivery—includes MD Anderson, Memorial Hermann, Methodist, Texas Children’s, St. Luke’s (60+ institutions, 10+ million patient visits annually)
• Inner Loop (610): $5 (Downtown, Midtown, Montrose, Heights, Rice Village, Museum District, River Oaks, Upper Kirby, Galleria)
• Within Beltway 8: $10 (Bellaire, Memorial, Spring Branch, South Houston, Pasadena, Hobby Airport area)
• Greater Houston suburbs: $15 (Katy, Sugar Land, Pearland, Clear Lake, Woodlands, Cypress, Tomball, Humble, Kingwood)
• Extended region (60 miles): $20-25 (Galveston, Baytown, Rosenberg, Conroe, La Porte, Seabrook)

Our free TMC delivery reflects our commitment to accessibility for patients who need it most—a principle we extend to remote communities like Pitcairn Islands through transparent international shipping.

PANDEM1C SEO Technology

Our proprietary PANDEM1C SEO system—14 million distinct geopolitical locations, 300+ AI models—drives organic search visibility globally, making our products discoverable to Pitcairn Islands residents searching in English for RSO information. You’re reading this because that technology worked.

Part 8: The OilWell Difference—Why Pitcairn Islands Residents Can Trust Us

Seven ABC13 Features—Mainstream Media Validation

Between September 2019 and April 2023, ABC13 Houston featured Colin Valencia in seven distinct news segments:

1. September 15, 2019—”Texas CBD businesses booming” (introduced our foundational philosophy)
2. March 22, 2021—”Entrepreneur creates direct-to-consumer business” (ecosystem building)
3. May 24, 2021—”What is Delta 8 THC” (iconic “maybe you want to get high” exchange)
4. August 20, 2021—”$35,000 COVID vaccine giveaway” (community health leadership)
5. October 19, 2021—”Delta 8 ban impact” (ethical crisis response)
6. October 7, 2022—”Biden marijuana pardon” (personal conviction history revealed)
7. April 21, 2023—”Marijuana industry getting creative” (Renaissance framing)

No other Houston cannabis operator appears with this frequency or breadth. Five different ABC13 reporters sought Colin out. When the station needed to explain cannabis products, legal changes, community health initiatives, or criminal justice impacts, they called Colin.

The Through-Line—What Media Recognition Means for Pitcairn Islands

Consistency Across Years: Through legal changes, product booms and bans, and political shifts, ABC13 returned to Colin as their primary source. For Pitcairn Islands residents, this demonstrates reliability—you’re not dealing with a fly-by-night operator, but a consistently recognized authority.

Breadth of Expertise: Business, law, medicine, community health, politics. This range shows deep industry understanding, not superficial marketing.

Community Action: The documented $35,000 COVID giveaway and proactive Delta-8 removal before enforcement show we act on values, not just profit.

Personal Stakes: The revelation of Colin’s personal marijuana conviction history (October 2022) proves we’re not outsiders exploiting cannabis—we’re people who’ve lived the consequences and built a legal business with integrity.

Evolution: From “local wholesaler” (2019) to industry authority (2023), our media trajectory mirrors legal cannabis’s maturation.

For Pitcairn Islands, this media record is independently verified credibility you can trust across 8,000 miles of ocean.

Our Complete Quote Index—Transparency in Our Voice

Here are all 13 Colin Valencia quotes from ABC13 features, showing consistency over four years:

1. “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” (Sept 2019)

2. “Pain comes in a lot of different forms.” (Mar 2021)

3. “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.” (May 2021)

4. “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!” (Aug 2021)

5. “[We’re] trying to get the city behind me to help as many people as we can. I really want to help things.” (Aug 2021)

6. “It’s going to be a surprise to a lot of people.” (Oct 2021—Delta-8 ban)

7. “It was a prime seller and a prime interest of customers, and they really enjoyed the benefits of it.” (Oct 2021)

8. “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.” (Oct 2021)

9. “It’s disappointing, but I’m not going to lose my customers and business are going to want our expertise on how to continue thriving in the industry.” (Oct 2021)

10. “You face challenges with housing, loans, and banking, I mean with about everything.” (Oct 2022—on conviction consequences)

11. “I would love to see people not get hurt for this anymore.” (Oct 2022)

12. “I want it to be legalized. I’m just saying that’s a very hyped conversation. If you really look at what’s here now, there’s nothing you could show me that I could accomplish with what literally we have right now.” (Apr 2023)

13. “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” (Apr 2023)

Bentley’s Original CBD Golden Paste Recipe—Still Published Free

The formula that saved Bentley remains publicly available on our website so any pet owner facing similar crisis can make it:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (crucial for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan, stir over low heat until thick paste forms (7-10 minutes)
2. Add coconut oil and pepper, stir until thoroughly mixed
3. Cool, transfer to jar, refrigerate up to two weeks
4. Add CBD oil before serving, adjusting dosage as needed

Serving: Mix small amount with pet’s food once or twice daily. Monitor changes and consult veterinarian.

We published this before we ever published our RSO formulas. This is who we are.

Part 9: Connect With Us—Pitcairn Islands Residents

How to Reach Us

• Phone: (832) 416-2816 (Houston, Texas—UTC-6)
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Instagram: @oilwellcbd
• Address: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

We’re a Houston-based company reaching out to Pitcairn Islands. We don’t claim physical presence in your territory, but we serve you with the same commitment we show our Houston neighbors.

Business Hours (Houston Time—UTC-6)

• Monday-Thursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

When calling from Pitcairn Islands (UTC-8), we’re 2 hours ahead. Best contact times: afternoon your time (morning ours) or early evening your time (late afternoon ours).

Specialized Products Beyond RSO

Asshole Peach—Our most popular product, particularly favored by veterans for PTSD and pain relief. Peach gummy rings with 268 mg total cannabinoids: 28 mg Delta-9 THC, 50 mg Delta-8 THC, 20 mg Delta-10 THC, 20 mg THCo, 100 mg CBD, 50 mg CBG. $39.99

Peace Gummies—Born from Colin’s personal benzo withdrawal experience. Developed during midnight experiments while fighting Xanax addiction. Each peach contains 320 mg total cannabinoids: 30 mg CBN, 15 mg Delta-9 THC, 25 mg Delta-8 THC, 100 mg CBD, 150 mg CBG. $34.99

SWEETEMintz—Sugar-free vegan peppermint hard candy for diabetics and health-conscious consumers. 28 mg Delta-9 Nano THC, 100 mg Nano CBD, 50 mg CBG Isolate. $39.99

Custom Creations—We design tailored products on request for specific cannabinoid ratios, delivery formats, or health circumstances including formulations for vegans, diabetics, and those with specific dietary needs.

Part 10: Final Thoughts—A Message to Pitcairn Islands

Living on Pitcairn Islands means you understand what it means to be resourceful, to look after your community, and to seek solutions when conventional options are limited. You know the value of self-reliance and the importance of trustworthy information.

We started OilWell Cannabis from that same place of desperation and discovery. Bentley’s story, Colin’s PTSD journey, our commitment to open-source formulas—all of it comes from understanding what it’s like to have limited options and to need something that actually works.

Our RSO formula represents the evolution of Rick Simpson’s vision. We honor his original ethos of accessibility and patient control while bringing modern science, safety testing, and legal compliance to a product that was once crude and risky. For Pitcairn Islands residents, this means you can access a clinically-informed, multi-cannabinoid formula that respects both the tradition and the evidence.

We don’t promise cures. We promise transparency, quality, and honest education. We promise that every cannabinoid and terpene in our formula is there for a reason—backed by the research summarized in this guide, included at functional doses, and tested for purity and safety.

Whether you’re dealing with chronic pain from years of physical island labor, sleep disturbances from the isolation and uncertainty, anxiety from limited medical access, or supporting someone through serious illness requiring evacuation, our products are designed to provide options. The raw THCa format gives you daytime relief without impairment. The decarboxylated option gives you full-potency therapeutic support when you need it most. The vape format gives you immediate relief for acute breakthrough symptoms.

And if our prices are beyond reach for your community’s budget, our open-source formulas mean you can potentially source ingredients and make your own version. That’s not a marketing gimmick—it’s our commitment to the principle that medicine should be accessible, especially in the most remote places on Earth.

We’re here to answer your questions, guide your dosing decisions, and support your journey with honest information. Call us, email us, reach out on Instagram. We’ll respond with the same directness and care we show our Houston neighbors.

The Pitcairn Islands community has survived and thrived through resilience and mutual support. We honor that spirit by offering you something that we believe represents the best of what cannabis medicine can be: honest, effective, safe, and accessible.

Thank you for taking the time to read this comprehensive guide. We hope it serves you well.

OilWell Cannabis
810 Richmond Ave, Houston, TX 77006
(832) 416-2816 | [email protected]
https://oilwellcbd.com/

Founded 2019 | Texas DSHS Licensed | Near-5.0 Google Rating | ~$1M Annual Revenue
All artwork, formulations, and packaging created in-house in Houston, Texas

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before use, especially if pregnant, nursing, have a medical condition, or take medications. Do not operate vehicles or machinery while using psychoactive cannabinoids. Keep out of reach of children. Buyer assumes responsibility for compliance with local laws. Products contain less than 0.3% delta-9 THC and are Farm Bill compliant. THCa converts to delta-9 THC when heated.
Age Requirement: 21+ only.
Legal Notice: Void where prohibited by law. International customers accept all customs and legal responsibility.

---